Moderna and BioNTech shares both fell to their lowest price in years on Monday as the companies behind the most widely-used mRNA COVID-19 vaccines grapple with investor disappointment with crashing revenues.
Scientists have uncovered startling evidence that many of the batches of the Pfizer vaccine deployed in the EU may have been placebos – and the regulator knew this and did not subject them to quality-control testing.
Who owns BioNTech, the pharmaceutical company that earned $31 billion from sales of its COVID-19 vaccine in 2021 and 2022? It's not who you think it is, says investigative reporter Robert Kogon.
In Eugyppius's latest post he describes the truly staggering number of Covid vaccine doses bought by the German Government that have expired because no one wants them and they cannot give them away to other countries.
According to the financial analyst Robert Kogon, the big winner from the Covid vaccine gold rush is not Pfizer, but BioNTech, which has made over $31 billion in Covid vaccine-related profits in the past two years.
Since the German Health Minister Karl Lauterbach gave an interview deploring the dismaying levels of vaccine injuries, the German media has published story after story about them. Read a sample, courtesy of Eugyppius.
